Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 23, 2023
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
[ Thu, Mar 23rd 2023
] - WOPRAI
Geulah Livshits Maintained (SNTI) at Strong Buy with Decreased Target to $70 on, Mar 23rd, 2023
Geulah Livshits of Chardan Capital, Maintained "Senti Biosciences, Inc." (SNTI) at Strong Buy with Decreased Target from $80 to $70 on, Mar 23rd, 2023.
Geulah has made no other calls on SNTI in the last 4 months.
There are 2 other peers that have a rating on SNTI. Out of the 2 peers that are also analyzing SNTI, all agree with Geulah's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $30 on, Friday, January 27th, 2023
- Brian Cheng of "JP Morgan" Initiated at Hold on, Friday, December 16th, 2022
